LAMPERT MARK N

CIK 000123384058 companiesSAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001233840

Recent Transactions

5 trades

Award
Cascadian Therapeutics, Inc.
Series D Convertible Preferred Stock
2016-06-23$800.00/sh+5,505→ 5,505 total
Award
Cascadian Therapeutics, Inc.
Series D Convertible Preferred Stock
2016-06-23$800.00/sh+1,029→ 1,029 total
Award
Cascadian Therapeutics, Inc.
Series D Convertible Preferred Stock
2016-06-23$800.00/sh+6,197→ 6,197 total
Award
Cascadian Therapeutics, Inc.
Series D Convertible Preferred Stock
2016-06-23$800.00/sh+4,519→ 4,519 total
Sale
ARENA PHARMACEUTICALS INC
Common Stock
2003-10-17$7.69/sh−2,911,000→ 4,520,212 total

Companies

4D Molecular Therapeutics, Inc.
See Explanation of Responses
$FDMT
ABBOTT BIOTHERAPEUTICS CORP
10% Owner
ADOLOR CORP
10% Owner
Allakos Inc.
10% Owner
ALPINE IMMUNE SCIENCES, INC.
10% Owner
ARENA PHARMACEUTICALS INC
Director, 10% Owner
ARQULE INC
10% Owner
ARRAY BIOPHARMA INC
10% Owner
Astex Pharmaceuticals, Inc
10% Owner
AVIGEN INC \DE
10% Owner
Calithera Biosciences, Inc.
10% Owner
Capstone Holding Corp.
10% Owner
$CAPS
Cascadian Therapeutics, Inc.
10% Owner
Celera CORP
10% Owner
ChemoCentryx, Inc.
10% Owner
CONCERT PHARMACEUTICALS, INC.
10% Owner
CRESCENT BIOPHARMA, INC.
10% Owner
$CBIO
CTI BIOPHARMA CORP
10% Owner
Cullinan Therapeutics, Inc.
10% Owner
$CGEM
CYTOKINETICS INC
10% Owner
$CYTK
CytomX Therapeutics, Inc.
10% Owner
$CTMX
DYNAVAX TECHNOLOGIES CORP
10% Owner
$DVAX
Eledon Pharmaceuticals, Inc.
10% Owner
$ELDN
enGene Holdings Inc.
10% Owner
$ENGN
EPIRUS Biopharmaceuticals, Inc.
10% Owner
ESSA Pharma Inc.
10% Owner
$EPIX
FIVE PRIME THERAPEUTICS, INC.
10% Owner
GYRE THERAPEUTICS, INC.
10% Owner
$GYRE
ICAGEN INC
10% Owner
IDEAYA Biosciences, Inc.
10% Owner
$IDYA
IMMUNE DESIGN CORP.
10% Owner
IMMUNIC, INC.
Director, See Explanation of Responses
$IMUX
INFINITY PHARMACEUTICALS, INC.
Director, 10% Owner
KENT INTERNATIONAL HOLDINGS INC
See Explanation of Responses
Kymera Therapeutics, Inc.
Director, See Remarks and Footnotes
$KYMR
LIGAND PHARMACEUTICALS INC
10% Owner, Indirect Beneficial Owner
$LGND
MEDICINOVA INC
10% Owner
$MNOV
Merus N.V.
10% Owner
$MRUS
MoonLake Immunotherapeutics
Director, 10% Owner
$MLTX
NEUROBIOLOGICAL TECHNOLOGIES INC /CA/
10% Owner
NEUROCRINE BIOSCIENCES INC
10% Owner
$NBIX
Olema Pharmaceuticals, Inc.
Director, See Explanation of Responses
$OLMA
PALATIN TECHNOLOGIES INC
10% Owner
$PTNT
PALVELLA THERAPEUTICS, INC.
10% Owner
$PVLA
POINT Biopharma Global Inc.
10% Owner
Principia Biopharma Inc.
10% Owner
Rain Oncology Inc.
See Explanation of Responses
Regulus Therapeutics Inc.
10% Owner
Repare Therapeutics Inc.
10% Owner
$RPTX
REPLIGEN CORP
10% Owner, Group Member
$RGEN
RIGEL PHARMACEUTICALS INC
10% Owner
$RIGL
Structure Therapeutics Inc.
10% Owner
$GPCR
Syndax Pharmaceuticals Inc
10% Owner
$SNDX
Third Harmonic Bio, Inc.
10% Owner
Tobira Therapeutics, Inc.
See Explanation of Responses
Verastem, Inc.
10% Owner
$VSTM
Xenon Pharmaceuticals Inc.
10% Owner
$XENE
XOMA Royalty Corp
10% Owner
$XOMA

Recent Filings

4
Cascadian Therapeutics, Inc.
Jun 27, 2016
4
LAMPERT MARK N
Oct 21, 2003

Address

44 MONTGOMERY ST. 40TH FLOOR

SAN FRANCISCO, CA, 94104

View on SEC.gov